Why Do Studies on Medicinal Cannabis and CBD Produce Such Different Results?

By Marcela Gottschald -

Clinical evidence on cannabidiol (CBD) and medicinal cannabis is often difficult to interpret because the term “CBD” can describe interventions that are pharmacologically quite different.

Unlike most conventional pharmaceuticals, cannabinoid-based preparations used in research are not always standardized in terms of cannabinoid content, formulation, dose, or route of administration. As a result, two studies investigating “CBD” may expose participants to substantially different interventions.

In This Article

    The Role of Product Composition

    In conventional pharmacological research, the active pharmaceutical ingredient is generally well characterized, and the dose and formulation are standardized. This allows researchers to reproduce the intervention and compare results across clinical trials with greater confidence.

    Cannabinoid research does not always have the same degree of standardization. Studies may investigate purified CBD, pharmaceutical formulations containing a defined concentration of CBD, or cannabis extracts containing CBD together with THC and other cannabinoids. The chemical composition of these preparations can differ substantially.

    This distinction is clinically relevant because CBD and tetrahydrocannabinol (THC) have different pharmacological profiles. CBD is not intoxicating in the way THC is, whereas THC produces the characteristic psychoactive effects of cannabis. The presence and concentration of THC can therefore influence both therapeutic effects and adverse effects, while the ratio between CBD and THC may also affect the overall response.

    CBD studies can produce conflicting results because cannabinoid products vary in composition, formulation, dosage, and route of administration.

    Dose, Formulation, and Pharmacokinetic Variability

    CBD doses used in clinical studies vary considerably, from relatively low doses to several hundred milligrams per day. However, comparing doses alone can be misleading because systemic exposure depends on formulation and route of administration as well as the nominal dose.

    Oral CBD has relatively low and variable bioavailability, and its absorption is influenced by factors including food intake and formulation. Lipid-based formulations, for example, can produce different pharmacokinetic profiles from other oral preparations. Consequently, two products containing the same nominal amount of CBD may not result in equivalent plasma exposure.

    The route of administration introduces another source of variation. Oral, sublingual, inhaled, and other routes differ in absorption, onset of action, bioavailability, and pharmacokinetics. These differences can influence both efficacy and tolerability and should be considered when comparing clinical studies.

    CBD versus whole-plant preparations

    Another important distinction is whether the intervention contains CBD alone or multiple cannabinoids.

    Cannabis contains more than 100 identified cannabinoids, although CBD and THC are the best characterized. Cannabis-based extracts may also contain minor cannabinoids and other constituents whose concentrations vary according to the plant material and manufacturing process.

    Consequently, a randomized trial of purified CBD should not automatically be considered equivalent to a trial of a CBD-rich cannabis extract. A preparation containing both CBD and THC represents a different pharmacological intervention, even when CBD is the predominant cannabinoid.

    This distinction becomes particularly important when evidence from different types of studies is combined in systematic reviews or used to inform clinical decisions. If the interventions are chemically and pharmacokinetically different, an apparent difference in efficacy may reflect differences in the preparations rather than differences in the underlying therapeutic potential of cannabinoids.

    The Importance of Standardization in Cannabinoid Research

    For clinicians, one of the most important implications is that evidence should be interpreted at the level of the specific cannabinoid preparation rather than cannabis or CBD as a broad category.

    A clinical trial demonstrating efficacy with a standardized pharmaceutical CBD formulation provides evidence for that formulation, dose, and indication. It does not necessarily establish equivalent efficacy for an over-the-counter CBD oil or a cannabis extract with a different cannabinoid profile.

    Greater standardization would make cannabinoid research easier to reproduce and would allow clinicians to compare evidence across trials with greater confidence. Until that happens, differences in cannabinoid composition, formulation, dose, route of administration, and study population need to be considered when evaluating apparently inconsistent findings.

    References ▼

    Comments

    Post a Comment

    Popular posts from this blog

    What We Expect From Medication

    By Marcela Gottschald -
    Image
    When someone starts a medication, there is usually an expectation attached to it. We expect the pain to decrease, the blood pressure to come down, an infection to resolve, a symptom to become manageable, or a future complication to become less likely. 
    Read more

    Signs of Anxiety You Should Know

    By Marcela Gottschald -
    Image
    Sometimes, anxiety does not feel like anxiety. It may look like a mind that will not slow down, a constant feeling that something is about to go wrong, or a body that seems to be reacting to a danger you cannot quite identify.
    Read more

    Women’s Health Is More Than Reproductive Health

    By Marcela Gottschald -
    Image
    Women’s health is often used as a synonym for reproductive health, as if the only difference between female and male bodies were the reproductive system. Saying this is not the same as saying that menstruation, pregnancy, contraception, fertility, and menopause are not important parts of women’s health. It's just a reminder that sex also affects other parts of the body.
    Read more